Doddanna Krishna, MD | |
44215 15th Street West, Suite 211, Lancaster, CA 93534 | |
(661) 726-6600 | |
(661) 726-6603 |
Full Name | Doddanna Krishna |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 46 Years |
Location | 44215 15th Street West, Lancaster, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285725945 | NPI | - | NPPES |
A43598 | Other | CA | CALIFORNIA MEDICAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | A43598 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Antelope Valley Hospital | Lancaster, CA | Hospital |
Palmdale Regional Medical Center | Palmdale, CA | Hospital |
Ridgecrest Regional Hospital | Ridgecrest, CA | Hospital |
Wellsprings Post Acute Center | Lancaster, CA | Nursing home |
Antelope Valley Care Center | Lancaster, CA | Nursing home |
The Ellison John Transitional Care Center | Lancaster, CA | Nursing home |
Desert Canyon Post Acute, Llc | Lancaster, CA | Nursing home |
Entity Name | Doddanna Krishna Md A Professional Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902997661 PECOS PAC ID: 5092839068 Enrollment ID: O20100826001144 |
News Archive
UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.
University of Arkansas scientists and educators are attacking childhood obesity in a project funded by a $4.78 million grant for five years from the National Institute of Food and Agriculture of the U.S. Department of Agriculture.
AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
› Verified 6 days ago
Entity Name | Av Critical Care Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144723800 PECOS PAC ID: 2365706702 Enrollment ID: O20180510001141 |
News Archive
UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.
University of Arkansas scientists and educators are attacking childhood obesity in a project funded by a $4.78 million grant for five years from the National Institute of Food and Agriculture of the U.S. Department of Agriculture.
AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
› Verified 6 days ago
Entity Name | Medstat Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609362227 PECOS PAC ID: 7315379229 Enrollment ID: O20191114002157 |
News Archive
UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.
University of Arkansas scientists and educators are attacking childhood obesity in a project funded by a $4.78 million grant for five years from the National Institute of Food and Agriculture of the U.S. Department of Agriculture.
AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Doddanna Krishna, MD 44215 15th Street West, Suite 211, Lancaster, CA 93534 Ph: (661) 726-6600 | Doddanna Krishna, MD 44215 15th Street West, Suite 211, Lancaster, CA 93534 Ph: (661) 726-6600 |
News Archive
UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.
University of Arkansas scientists and educators are attacking childhood obesity in a project funded by a $4.78 million grant for five years from the National Institute of Food and Agriculture of the U.S. Department of Agriculture.
AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
› Verified 6 days ago
Dr. Tanyanika Phillips, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 44151 15th St W Ste 101, Lancaster, CA 93534 Phone: 661-902-5600 Fax: 661-951-0686 | |
Dr. Violeta Vallejo-sinavsky, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 44900 60th St W, Lancaster, CA 93536 Phone: 661-948-8581 Fax: 661-945-8474 | |
Justin Chang, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 43112 15th St W, Lancaster, CA 93534 Phone: 626-380-5527 | |
Dr. Qiyuan Dai, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 45104 10th St W, Lancaster, CA 93534 Phone: 661-942-2391 Fax: 661-942-2391 | |
Karandeep Singh, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 45104 10th St W, Lancaster, CA 93534 Phone: 562-867-7999 | |
Zin Win, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 43112 15th St W, Lancaster, CA 93534 Phone: 661-726-2245 | |
Pye Aung, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 W Avenue J, Lancaster, CA 93534 Phone: 661-726-6254 |